R O Dillman

发表

Statistical approach to immunosuppression classification using lymphocyte surface markers and functional assays.

J A Koziol, J. Koziol, R. Dillman, 1983, Cancer research.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

J. Herndon, Mark R. Green, R. Dillman, 1996, Journal of the National Cancer Institute.

Human immune response to multiple injections of murine monoclonal IgG.

L. M. Smith, R. Dillman, R O Dillman, 1985, Journal of immunology.

Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer.

R. Dillman, R O Dillman, C C Malone, 2001, Cancer biotherapy & radiopharmaceuticals.